Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response.

about

Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsers.Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study.

P2860

Q43892504-1436F8C4-9C3C-425D-826D-50ACE6C61EEC Q44778300-79B6C89D-F4EA-48F9-A8A7-99D8B1EE2917

P2860

Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response.

Item

http://www.wikidata.org/entity/Q43001692

description

2001 nî lūn-bûn

@nan

2001年の論文

@ja

2001年学术文章

@wuu

2001年学术文章

@zh

2001年学术文章

@zh-cn

2001年学术文章

@zh-hans

2001年学术文章

@zh-my

2001年学术文章

@zh-sg

2001年學術文章

@yue

2001年學術文章

@zh-hant

name

Time course of serum hepatitis ...... predicts the type of response.

@en

Time course of serum hepatitis ...... predicts the type of response.

@nl

type

Item

label

Time course of serum hepatitis ...... predicts the type of response.

@en

Time course of serum hepatitis ...... predicts the type of response.

@nl

prefLabel

Time course of serum hepatitis ...... predicts the type of response.

@en

Time course of serum hepatitis ...... predicts the type of response.

@nl

P1476

Time course of serum hepatitis ...... predicts the type of response.

@en

P2093

Albillos A

http://www.w3.org/2001/XMLSchema#string

Calleja JL

http://www.w3.org/2001/XMLSchema#string

Domper F

http://www.w3.org/2001/XMLSchema#string

Escartín P

http://www.w3.org/2001/XMLSchema#string

Martínez JL

http://www.w3.org/2001/XMLSchema#string

Moreno R

http://www.w3.org/2001/XMLSchema#string

Rossi I

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

A pilot study of ribavirin therapy for chronic hepatitis C

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions.

Factors predictive of a beneficial response to therapy of hepatitis C.

Changes in serum hepatitis C virus RNA in interferon nonresponders retreated with interferon plus ribavirin: a preliminary report.

Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study.

Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets.

P304

241-249

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2036.2001.00921.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2001-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12181802

http://www.w3.org/2001/XMLSchema#string

P698

11148444

http://www.w3.org/2001/XMLSchema#string

Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response.

about

P2860

P2860

Time course of serum hepatitis C virus-RNA during chronic hepatitis C treatment accurately predicts the type of response.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698